NCT06860594 2026-06-05Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or AstrocytomaNational Cancer Institute (NCI)Phase 1 Suspended30 enrolled